A pathogenic role for Streptococcus pyogenes infections in chronic plaque psoriasis is suspected but poorly defined. We separated cellular and supernatant proteins from S pyogenes cultures by high-resolution two-dimensional gel electrophoresis, and used immunoblotting to demonstrate the diversity of serum or plasma IgGs that react with elements of the proteome of this bacterium. We have shown that a substantial proportion of IgG-reactive proteins from cultured S pyogenes are secreted. The total secreted protein fraction, including diverse IgG-binding elements, was subsequently used in an ELISA to measure blood titers of reactive IgG. This ELISA showed that blood samples from patients with chronic plaque psoriasis contained significantly higher titers of reactive IgG than samples from age-and sex-matched healthy controls (p = 0.0009). In contrast, neither a standard assay measuring antistreptolysin O titers nor ELISAs measuring titers of IgG reactive with protein fractions from Staphylococcus aureus and Staphylococcus epidermidis, were able to distinguish between blood samples from the two groups. These findings justify the hypothesis that S pyogenes infections are more important in the pathogenesis of chronic plaque psoriasis than has previously been recognised, and indicate the need for further controlled therapeutic trials of antibacterial measures in this common skin disease.
INTRODUCTION
The pathogenesis of psoriasis depends on genetic susceptibility especially in disease of earlier onset, and mechanisms suggestive of autoimmunity (Griffiths et al., 2004) . The provocation of autoimmune diseases such as rheumatic fever and acute glomerulonephritis by infection with Streptococcus (S) pyogenes is well recognised and may depend on immunological mimicry between molecules expressed by the bacterium and target tissue (Cunningham 2000; Bisno et al., 2003) . There is also a convincing association between streptococcal pharyngitis and exacerbations of acute guttate psoriasis, the less common, small plaque variant (Telfer et al., 1994) . Some have implicated the expansion of autoreactive T lymphocytes by released bacterial superantigens in the pathogenesis of post-streptococcal guttate psoriasis (Valdimarsson et al., 1995) as well as immunological mimicry between microbial surface M proteins (Gudjonsson et al., 2004) or the group A-specific carbohydrate Nacetyl-β-D-glucosamine (Shikhman and Cunningham, 1994) and epidermal keratins.
Association between S pyogenes infection and the much commoner chronic plaque type of psoriasis is poorly defined but of potential importance, particularly if a subgroup of patients with occult infection can be identified and disease severity improved by appropriate antibacterial measures. This association has been suggested by several uncontrolled reports of improvement following tonsillectomy (Owen et al., 2001 ) and an anecdotal report of improvement following short-term antibiotics in a small number of patients with chronic plaque psoriasis (Rosenberg et al., 1986) . Two recent reports indicating that streptococcal infections are more frequent in patients with chronic plaque psoriasis than healthy controls remain inconclusive because the two groups were apparently not age-matched (Fry et al., 2006; Weisenseel et al., 2002) , an important requirement in such studies since streptococcal infections are known to be commoner in younger people (Cunningham, 2000) . Recent epidemiological work also suggests that patients with chronic plaque psoriasis experience more frequent streptococcal sore 4 throats than controls and that these infections may provoke deterioration in disease severity (Gudjonsson et al., 2003) . Other than these reports, there is little evidence to support an association between S pyogenes infections and chronic plaque psoriasis.
However, during a preliminary study aimed at exploring the structure of immunoreactive S pyogenes proteins and their homology to skin proteins, we noted increased levels of S pyogenes-reactive IgG in serum from chronic plaque psoriasis patients versus healthy controls, and have now extended this finding. (Figure 1b) . Probing of two-dimensional western blots of S pyogenes supernatant proteins with pooled sera from 8 age-and sex-matched healthy controls showed that the IgGs from this source react with a rather similar profile of proteins to those bound by IgGs in pooled psoriatic sera. However, the staining was less intense when control sera were used, suggesting that titers of S pyogenes-reactive IgG are lower in control than psoriatic sera (Figure 1e ). These observations were consistent in three separate analyses with cellular and supernatant proteins from different cultures of the same S pyogenes and pooled sera from 6-8 patients and matched healthy controls.
RESULTS

A substantial proportion of
Titres of IgGs that bind to S pyogenes total secreted protein fraction are significantly higher in psoriatic than control blood samples Venous blood was obtained from patients with chronic plaque psoriasis (28 females and 29 males, aged 17-80 years; mean age ± SD 43 ± 15 years) who had attended the dermatology clinics of the Leicester Royal Infirmary or Hope Hospital, Manchester. Most of the patients had moderate to severe disease, giving a median psoriasis area and severity index (Fredricksson and Pettersson, 1978) of 13⋅6 ± 7.0 (SD). None had received systemic anti-psoriatic drugs or UV therapy for at least two months before venesection. Control subjects were healthy age-and sex-matched volunteers (20 females and 20 males aged 18-80 years; mean age ± SD 42 ± 17 years). We developed a novel, quantitative ELISA that used total proteins secreted by cultured S pyogenes as substrate, to show that titers of IgG that reacted with the total secreted protein fraction were significantly higher in serum or plasma samples from the patients with chronic plaque psoriasis (1000 ± 201, median ± SE, n = 57) than in samples from the age-and sex-matched healthy controls (200 ± 120, median ± SE, n = 40; p = 0.0009, Mann-Whitney test; Figure 2a ). There was no correlation between the titer of two-dimensional gels, concentrated supernatant being essentially protein-free (data not shown), a finding consistent with evidence that pathogenicity depends on protein secretion in many bacteria (Rosch and Caparon, 2004) . In contrast to the findings with S pyogenes proteins, ELISAs with protein fractions from these alternative bacteria showed little or no difference between levels of reactive IgG in pooled sera from patients with chronic plaque psoriasis versus controls (Figure 3 ).
DISCUSSION
The finding that IgG responses of psoriasis patients focus significantly on proteins in supernatants of S pyogenes cultures is compatible with the known protein-secreting capacity of this bacterium (Cunningham, 2000) and thus the availability of these proteins to the immune system. Serum IgG responses of psoriasis patients to secreted S pyogenes proteins were also found to be higher than IgG responses to cellular proteins in the present work, as shown initially by immunoblotting (Figure 1 ). Furthermore, 6/22 psoriatic blood samples (27%) gave IgG ELISA titers of >500 in response to the cellular protein fraction, whereas 29/57 psoriatic samples (51%) gave titers of >500 in response to the secreted protein fraction (Figure 2 ). These differences could be due to the described antiphagocytic properties of S pyogenes, which appear at least in part to be associated with hyaluronate encapsulation and with the ability of streptococcal surface M protein to bind serum factor H and fibrinogen, which inhibit complement activation (Cunningham, 2000; Bisno et al., 2003) . Thus, it is possible that failure of opsonisation and decreased phagocytosis of intact streptococci by antigen presenting cells are associated with impaired T cell activation by streptococcal cellular proteins and thus reduced T cell-dependent synthesis of antibodies (DeFranco, 1987) that recognise these cellular proteins.
The S pyogenes cultures used in in the present work were derived from the same parent culture, which expressed M protein (serotype M5), a fibrous surface protein that has well-recognized immunogenic properties (Cunningham, 2000; Gudjonsson et al., 2004) . However, the levels of M protein in the different total protein fractions we have used to develop our assays have not been established, and the contributions of this 8 protein to the IgG ELISA reactivities described are not known. Nevertheless, it is likely that a substantial component of the S pyogenes cellular fraction used in the ELISAs illustrated in Figure 2c (which included insoluble cellular fragments) contained M protein. This highlights the potential importance of our finding of higher levels of IgG reactivity amongst secreted S pyogenes proteins than cellular proteins, a finding that appears not to have been described previously and may have relevance in vaccine design.
Our work shows that a significantly greater number of patients with chronic plaque psoriasis than healthy controls have raised blood titres of IgG reactive with total proteins secreted by S pyogenes. The significance of these findings is enhanced by the fact that age-matched controls were used, as S pyogenes infections are known to be more common in younger subjects (Cunningham, 2000) , and also by the fact that blood from the two sets of donors contained similar titres of IgG reactive with protein fractions from the other bacteria tested.
Demonstration of the large diversity of IgG-reactive proteins secreted by S pyogenes (Figure 1c ) justified the use of the total secreted protein fraction in our novel ELISA and is the likely explanation for its greater sensitivity in detecting humoral immunoreactivity to the bacterium, than that of a standard assay in clinical use that measures immune responses to only a single protein reactant, streptolysin O. Our results do not determine whether the ELISA-positive chronic plaque psoriasis patients have suffered from recent S pyogenes infections, are exposed to long-lived streptococcal antigens for example as a result of low level bacterial carriage, or whether the raised IgG titres might represent past infection and ongoing immunity. Nevertheless, the findings implicate these infections in the pathogenesis of psoriasis, possibly through immunological mimicry.
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We have recently identified a number of serum IgG-binding antigens in the proteome of psoriatic lesional epidermis, including arginase 1, enolase 1, keratin 10 and 60 kD heat shock protein (unpublished data). NCBI BLAST searches show that human arginase 1, enolase 1 and 60 kD heat shock protein all share substantial homology with similar proteins of S pyogenes. A credible molecular basis for immunological mimicry between proteins expressed by S pyogenes and psoriatic epidermis therefore exists, in addition to the previously proposed mimicry between surface M proteins of S pyogenes or the group A-specific carbohydrate N-acetyl-β-D-glucosamine and epidermal keratins (Gudjonsson et al., 2004; Rosenberg et al., 1986; Shikhman and Cunningham, 1994) .
Our findings suggest that better recognition, long-term prevention and treatment of S pyogenes infections may be important in the management of chronic plaque psoriasis.
There is a need for randomised, controlled trials of appropriate long-term antibiotics or even tonsillectomy, as suggested by systematic review (Owen et al., 2001) , especially targeted at those patients with raised titres of S pyogenes-reactive IgG. The need for such trials is highlighted by the recent report of remarkable improvement of chronic plaque psoriasis in an uncontrolled study of 30 Indian patients treated with repeated intramuscular injections of benzathine penicillin for at least 48 weeks (Saxena and Dogra, 2005) . Such treatment may provide a cost effective alternative to potentially toxic systemic agents including the emerging high-cost biologic therapies.
MATERIALS AND METHODS
Blood samples
This study was approved by the local research ethics committee and was conducted in accordance with Declaration of Helsinki protocols. Written, informed consent was obtained from each donor. Following venesection, blood samples were allowed to clot in glass test tubes, serum was removed and centrifuged to deplete cells. In some cases, venous blood was mixed with heparin and plasma obtained following centrifugation. Serum and plasma samples were stored at -80°C in aliquots.
Production and separation of bacterial proteins
A single, prevalent M5 serotype of S pyogenes (expressing type 5 surface M-protein), was obtained from the Public Health Laboratory Service, Colindale, UK, and cultured overnight in up to 6 liters of freshly-prepared, chemically-defined, protein-free medium (van de Rijn and Kessler, 1980) . Culture supernatant containing released proteins was recovered after centrifugation at 2000 g and concentrated by ammonium sulphate precipitation. Precipitate was redissolved in pH 7.7 buffer containing 8 mM sodium phosphate, 1.5 mM potassium phosphate, 2.5 mM potassium chloride, 0.5 mM PMSF and 1 mM EDTA. This was dialysed in 3.5 kD cut-off Slide-A-Lyzer™ cassettes (Perbio, Cramlington, UK) with up to six 2 liter volumes of the same buffer (without PMSF or EDTA), depending on the concentration of ammonium sulphate in the dialysis fluid, which was monitored with Nessler's reagent (Sigma, Poole, UK). Dialysed proteins were freeze-dried, the residue redissolved in the same dialysis buffer and desalted on Pierce spin minicolumns (product code 89866, Perbio), eluting with buffer containing 7 M urea, 2 M thiourea and 4% CHAPS in accordance with the supplier's instructions.
The eluate was mixed with rehydration buffer containing the above concentrations of urea, thiourea, and CHAPS, 2% ampholytes (Bio-Rad, Hemel Hempstead, U.K.) and 100 mM DeStreak reagent (Amersham, Little Chalfont, UK) to a final protein concentration of 1 μg/μl. Batches of proteins (300 μg) were separated on 17cm pH 3-10
ReadyStrip IPG strips in a Protean IEF cell (Bio-Rad). Strips were equilibrated according to the Bio-Rad instruction manual then laid on up to six 20 cm x 20 cm x 1 mm 12% acrylamide gels, which were run in parallel in an Ettan™ DALTsix electrophoresis unit (Amersham) under denaturing conditions. Pelleted bacteria from the same S pyogenes cultures were resuspended in PBS containing 0.5 mM PMSF and 1 mM EDTA and repeatedly sonicated on ice (up to 10 times) for 15 s at 8 micron amplitude and 45 s intervals. Sonicates were desalted and subjected to twodimensional electrophoresis as above.
Western blotting
Acrylamide gels were either stained directly with Coomassie blue G250 (Candiano et al., 2004) or electroblotted onto 20 cm x 20 cm Hybond-ECL™ nitrocellulose membranes (Amersham). Membranes were blocked with 5% skimmed milk powder in PBS at 4°C overnight, washed four times in PBS containing 0.05% Tween 20 (PBS/T), then probed with pooled sera diluted 1:2000 with PBS containing 1% skimmed milk powder for 2 h at room temperature. Following four washes in PBS/T, membranes were incubated with alkaline phosphatase-labelled goat anti-human IgG (product code A 3188, Sigma) diluted 1:4000 with PBS containing 1% skimmed milk powder for 90 min at room temperature, followed by four further washes and addition of 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium chloride substrate solution (Sigma) in accordance with the supplier's instructions.
ELISAs and agglutination assay
Batches of secreted S pyogenes proteins were concentrated from overnight culture supernatants, dialysed and freeze-dried as described above. Residues were redissolved in coating buffer (50 mM sodium bicarbonate buffer pH 9⋅6), 500 ng aliquots were added to the wells of Maxisorb microtiter plates (Nunc, Roskilde, Denmark) and left at 4°C overnight. Pelleted S pyogenes bacteria from the same overnight cultures were sonicated as described above, in PBS containing EDTA and PMSF. The sonicate was then diluted in a great excess of coating buffer (>2000:1) to a final protein concentration of 500 ng in 100 μl, and 100 μl aliquots used to coat microtiter plate wells. 
